Realbotix Corp. XBOTF
—
0.19
0.00
0.00%
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow XBOTF
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
70.85 | 43.88 | 43.93 | 36.45 | |
P/FCF ratio |
76.22 | 24.36 | 33.32 | 43.74 | |
P/Operating CF |
(29.09) | (36.42) | (54.56) | (33.24) | |
P/B ratio |
8.64 | 5.54 | 8.82 | 20.04 | |
Price to Tangible BV |
9.86 | 6.19 | 10.09 | 28.26 | |
EV/Sales |
64.98 | 38.06 | 39.20 | 34.39 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(7.85) | (7.77) | (12.03) | (12.78) | |
EV/FCF |
69.90 | 21.13 | 29.73 | 41.26 | |
Quick Ratio |
6.07 | 5.43 | 5.48 | 2.22 | |
Current Ratio |
6.72 | 5.80 | 5.86 | 2.43 | |
Net Debt/EBITDA |
3.04 | (10.89) | 5.19 | 1.80 | |
Debt/Assets |
5.53% | 0.00% | 0.11% | 14.59% | |
Debt/Equity |
0.07 | 0.00 | 0.00 | 0.28 | |
Asset Turnover |
0.10 | 0.12 | 0.14 | 0.21 | |
Operating CF/Net income |
1.09 | (3.26) | 0.93 | 2.52 | |
Capex/Depreciation |
9.78 | 0.67 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 35.30% | (439.06%) | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 255.33% | (786.20%) | |
Intangible Assets out of Total Assets |
0.10 | 0.09 | 0.11 | 0.15 | |
Share Based Compensation of Revenue |
9.15% | 115.41% | 94.33% | 49.23% | |
Graham Net Nets |
0.09 | 0.16 | 0.10 | 0.03 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(7.92%) | (6.14%) | (10.91%) | (6.73%) | |
Free Cash Flow Yield |
1.31% | 4.10% | 3.00% | 2.29% | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex per Share |
0.01 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Cash per Share |
0.02 | 0.03 | 0.03 | 0.03 | |
Shareholders Equity per Share |
0.03 | 0.04 | 0.04 | 0.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.03 | 0.04 | 0.04 | 0.02 | |
Free Cash Flow |
(0.47) | (1.16) | (1.25) | (2.21) | |
Working Capital |
5.51 | 7.33 | 6.61 | 3.41 | |
Capital Expenditures |
1.50 | 0.10 | — | — | |
Net Current Asset Value |
5.07 | 7.33 | 6.60 | 2.38 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(4.23) | (0.44) | 0.00 | 0.00 | |
Net Profit Margin |
(511.55%) | 171.94% | (380.40%) | 707.67% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.52 | 1.15 | 0.07 | 0.09 | |
Average Payables |
0.46 | 0.77 | 0.62 | 0.51 | |
Average Inventory |
0.39 | 0.41 | 0.34 | 0.38 | |
Average Assets |
7.77 | 8.71 | 10.92 | 9.65 | |
Average Common Equity |
5.69 | 6.31 | 8.40 | 5.84 |
Columns are period end dates · fundamentals updated 24 Sep 2026